Junshi BioPharma is an innovation-driven biopharmaceutical company which is dedicated to the discovery and development of innovative drugs and their clinical research and commercialization on a global scale. Our mission is to provide patients with treatment options that work better and cost less. Based on the core platform technology of protein engineering, Junshi stands at the frontier of R&D of macromolecular drugs. With distinguished capability of innovative drug discovery, advanced biotechnological R&D, large-scale production capacity on the full industry chain and rapidly expanding drug candidate portfolio of tremendous market potential, Junshi has a leading edge in the PRC in the emerging field of immuno-oncology and for the treatment of autoimmune and metabolic diseases. Junshi is the first PRC company filing IND application and NDA application to the NMPA for anti-PD-1 monoclonal antibody, and also the first PRC company to receive IND approvals from the NMPA for anti-PCSK9 monoclonal antibody and anti-BLyS monoclonal antibody. Our vision is to become a pioneer in the area of translational medicine by developing first-in-class and best-in-class drugs through original innovation. With enrichment of our product pipelines and exploration of drug combination therapies, Junshi expanded its innovation to the R&D of more types of drugs, including small molecule drugs and antibody drug conjugates (or ADCs), as well as to the exploration of the next-generation innovative therapies for cancer and autoimmune diseases.
Company Details
Shanghai Junshi Biosciences Co Ltd Questions
Shanghai Junshi Biosciences Co Ltd's website is http://junshipharma.com/en/Index.html
Shanghai Junshi Biosciences Co Ltd's LinkedIn profile is https://www.linkedin.com/company/shanghai-junshi-biosciences
Shanghai Junshi Biosciences Co Ltd has
214 employees.
View email and phone details for 214
employees at Shanghai Junshi Biosciences Co Ltd.
Shanghai Junshi Biosciences Co Ltd's industry is
Biotechnology
Shanghai Junshi Biosciences Co Ltd's top competitors are
Fosun Pharma,
Hengrui Pharma,
Zai Lab,
Innovent Biologics,
Incyte,
Beigene,
I-Mab Biopharma,
Coherus Oncology,
Cstone Pharmaceuticals,
Topalliance Biosciences Inc.
Shanghai Junshi Biosciences Co Ltd's categories are Biotechnology
Shanghai Junshi Biosciences Co Ltd's founding year is 2012
